Kessler Investment Group’s Zimmer Biomet ZBH Stock Holding History

Kessler Investment Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-96	Closed	-$8.76K	–	212
2025 Q2	$8.76K	Hold	96	–	–	﹤0.01%	142
2025 Q1	$10.9K	Hold	96	–	–	0.01%	139
2024 Q4	$10.1K	Hold	96	–	–	﹤0.01%	123
2024 Q3	$10.4K	Hold	96	–	–	0.01%	123
2024 Q2	$10.4K	Hold	96	–	–	0.01%	132
2024 Q1	$12.7K	Hold	96	–	–	0.01%	122
2023 Q4	$11.7K	Hold	96	–	–	0.01%	124
2023 Q3	$10.8K	Hold	96	–	–	0.01%	111
2023 Q2	$14K	Hold	96	–	–	0.01%	109
2023 Q1	$12.4K	Hold	96	–	–	0.01%	124
2022 Q4	$12K	Hold	96	–	–	0.01%	111
2022 Q3	$10K	Hold	96	–	–	0.01%	133
2022 Q2	$10K	Buy	+96	New	+$11.4K	0.01%	125

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Kessler Investment Group's ZBH Position: Q3 2025 in Review

Kessler Investment Group sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 96 shares — an estimated $8.76K sold.

Kessler Investment Group first reported a position in ZBH in Q2 2022 and held it in 13 quarters. The position peaked at $14K in Q2 2023. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Kessler Investment Group reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Kessler Investment Group sold 96 Zimmer Biomet shares in Q3 2025, an estimated $8.76K.
Kessler Investment Group first reported a position in Zimmer Biomet in Q2 2022 and held it in 13 quarters.
Kessler Investment Group's Zimmer Biomet position peaked at $14K in Q2 2023.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Kessler Investment Group's 13F filing for Q3 2025, filed 9 Oct 2025.